http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014065275-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2534bb9f13460c6429c25acf8df25d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_264627c9d405ca3e91c884db5fc908ad
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-04
filingDate 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d39dc85d96444f99b6d229a6ac2c71b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff2e1e7a24568e5102af3ace495a9610
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e228f66c5ddcc41a3505ad2b8abc8c00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c634973a4809b968dc5e4988afa185
publicationDate 2014-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014065275-A1
titleOfInvention Therapeutic or prophylactic agent for tumor lysis syndrome
abstract The purpose of the present invention is to provide a novel therapeutic or prophylactic agent for tumor lysis syndrome. The present invention is a therapeutic or prophylactic agent for tumor lysis syndrome, which comprises a 2-phenylthiazole compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
priorityDate 2012-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9209279-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005121153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010113942-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007043457-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010509372-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID547494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227130698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226451106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129652323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322225995

Total number of triples: 38.